@article{f57c673e8ab543aaab29b524cd130d00,
title = "Novel once-daily extended-release tacrolimus versus twice-daily tacrolimus in de novo kidney transplant recipients: Two-year results of phase 3, double-blind, randomized trial",
keywords = "Envarsus, Immunosuppression, bioavailability, biopsy-proven acute rejection, efficacy, end-stage renal disease (ESRD), extended-release, formulation, kidney transplantation, pill burden, randomized controlled trial (RCT), safety, tacrolimus, transplant recipient, treatment failure",
author = "Lionel Rostaing and Suphamai Bunnapradist and Griny{\'o}, {Josep M.} and Kazimierz Ciechanowski and Denny, {Jason E.} and Silva, {Helio Tedesco} and Klemens Budde",
note = "Publisher Copyright: {\textcopyright} 2016 The Authors.",
year = "2016",
month = apr,
day = "1",
doi = "10.1053/j.ajkd.2015.10.024",
language = "English",
volume = "67",
pages = "648--659",
journal = "American Journal of Kidney Diseases",
issn = "0272-6386",
number = "4",
}